• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

国家结直肠癌筛查计划实施 6 年后对结直肠癌发病率和 5 年生存率的影响。

The impact of 6 years of the National Colorectal Cancer Screening Program on colorectal cancer incidence and 5-year survival.

机构信息

AM DC Rogaška, Department of Gastroenterology, Rogaška Slatina.

National Institute for Public Health, Department SVIT, Ljubljana.

出版信息

Eur J Cancer Prev. 2021 Jul 1;30(4):304-310. doi: 10.1097/CEJ.0000000000000628.

DOI:10.1097/CEJ.0000000000000628
PMID:33369945
Abstract

We aimed to assess the impact of the first three rounds of the National Colorectal Cancer Screening Program (NCCSP) on CRC incidence and mortality in Slovenia. In NCCSP, we use two fecal immune tests (FITs) and if test is positive patient is referred to colonoscopy. From 2009, we invite Slovenian residents aged 50-69 years, one screening round takes 2 years. The response rate was from 56.9 to 59.9%. FIT was positive in 6.0-6.2% (more in older patients and in men; P < 0.05). The adenoma detection rate was >51.3% (more in men; P < 0.01). In NCCSP, 70.3% of all cancers diagnosed were in stages I and II, while 20.7% of all CRC were found in polyps resected during colonoscopies. Patients with positive first FIT have odds ratio 2.19 [95% confidence interval (CI), 2.06-2.32] for advanced neoplasia and cancer compared to patients with two negative FITs. The incidence rate for CRC has dropped significantly after 6 years in population and in men (P < 0.01) but not in women. Five-year CRC survival was 31.3% higher if cancer was diagnosed in NCCSP (P < 0.05). After 6 years of NCCSP, the incidence rate for CRC has dropped significantly (P < 0.01). Hazard ratio for death from CRC was 3.84 higher (95% CI, 3.36-4.40; P < 0.001) in patients with cancer detected outside the program.

摘要

我们旨在评估斯洛文尼亚国家结直肠癌筛查计划(NCCSP)前三轮对 CRC 发病率和死亡率的影响。在 NCCSP 中,我们使用两种粪便免疫测试(FIT),如果测试呈阳性,患者将被转介至结肠镜检查。从 2009 年开始,我们邀请 50-69 岁的斯洛文尼亚居民参加,一轮筛查持续 2 年。响应率为 56.9%至 59.9%。FIT 呈阳性的比例为 6.0-6.2%(年龄较大的患者和男性中更高;P<0.05)。腺瘤检出率>51.3%(男性中更高;P<0.01)。在 NCCSP 中,诊断出的所有癌症中 70.3%处于 I 期和 II 期,而所有 CRC 中有 20.7%是在结肠镜检查中切除的息肉中发现的。与两次 FIT 均为阴性的患者相比,首次 FIT 阳性的患者患有晚期肿瘤和癌症的优势比为 2.19(95%置信区间,2.06-2.32)。在人群和男性中,NCCSP 实施 6 年后 CRC 的发病率显著下降(P<0.01),但在女性中没有下降。如果癌症在 NCCSP 中诊断出,CRC 的 5 年生存率提高了 31.3%(P<0.05)。在 NCCSP 实施 6 年后,CRC 的发病率显著下降(P<0.01)。在计划外检测到癌症的患者死于 CRC 的风险比(HR)为 3.84(95% CI,3.36-4.40;P<0.001)。

相似文献

1
The impact of 6 years of the National Colorectal Cancer Screening Program on colorectal cancer incidence and 5-year survival.国家结直肠癌筛查计划实施 6 年后对结直肠癌发病率和 5 年生存率的影响。
Eur J Cancer Prev. 2021 Jul 1;30(4):304-310. doi: 10.1097/CEJ.0000000000000628.
2
Diagnostic Yield of One-Time Colonoscopy vs One-Time Flexible Sigmoidoscopy vs Multiple Rounds of Mailed Fecal Immunohistochemical Tests in Colorectal Cancer Screening.在结直肠癌筛查中,一次性结肠镜检查与一次性乙状结肠镜检查和多次邮寄粪便免疫化学检测的诊断收益比较。
Clin Gastroenterol Hepatol. 2020 Mar;18(3):667-675.e1. doi: 10.1016/j.cgh.2019.08.015. Epub 2019 Aug 13.
3
Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.多次粪便免疫化学检测受试者的间期结直肠癌发病率。
Gastroenterology. 2017 Aug;153(2):439-447.e2. doi: 10.1053/j.gastro.2017.05.004. Epub 2017 May 5.
4
Interval cancers in a population-based screening program for colorectal cancer with gender-specific cut-off levels for fecal immunochemical test.基于人群的结直肠癌筛查计划中,粪便免疫化学试验采用性别特异性截断值时的间隔期癌症。
J Med Screen. 2022 Sep;29(3):156-165. doi: 10.1177/09691413221085218. Epub 2022 Mar 8.
5
Results of the FIT-based National Colorectal Cancer Screening Program in Slovenia.斯洛文尼亚基于粪便免疫化学检测的全国结直肠癌筛查项目结果。
J Clin Gastroenterol. 2017 Jul;51(6):e52-e59. doi: 10.1097/MCG.0000000000000662.
6
Long-term performance of colorectal cancerscreening programmes based on the faecal immunochemical test.基于粪便免疫化学试验的结直肠癌筛查方案的长期效果。
Gut. 2018 Dec;67(12):2124-2130. doi: 10.1136/gutjnl-2017-314753. Epub 2017 Nov 3.
7
Factors associated with interval colorectal cancer after negative FIT: Results of two screening rounds in the Dutch FIT-based CRC screening program.阴性粪便免疫化学检测(FIT)后与结直肠癌间隔期相关的因素:荷兰基于 FIT 的 CRC 筛查计划中两次筛查轮次的结果。
Int J Cancer. 2023 Apr 15;152(8):1536-1546. doi: 10.1002/ijc.34373. Epub 2022 Dec 1.
8
Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer.粪便检测阴性的结直肠癌患者发生高级别腺瘤风险较低。
Gastroenterology. 2012 Mar;142(3):497-504. doi: 10.1053/j.gastro.2011.11.024. Epub 2011 Nov 19.
9
Incidence of Interval Colorectal Cancer After Negative Results From First-Round Fecal Immunochemical Screening Tests, by Cutoff Value and Participant Sex and Age.第一轮粪便免疫化学筛选试验阴性结果后间隔期结直肠癌的发生率,按截止值和参与者的性别及年龄划分。
Clin Gastroenterol Hepatol. 2020 Jun;18(7):1493-1500. doi: 10.1016/j.cgh.2019.08.021. Epub 2019 Aug 20.
10
Multiple Negative Fecal Immunochemical Tests Reduce Risk of Advanced Neoplasia in a Colonoscopy Surveillance Program.多次阴性粪便免疫化学检测可降低结肠镜监测计划中高级别腺瘤的风险。
Clin Gastroenterol Hepatol. 2023 Aug;21(9):2389-2398.e2. doi: 10.1016/j.cgh.2022.12.024. Epub 2023 Jan 5.

引用本文的文献

1
PA-MSHA exerts potent activity against cetuximab-resistant colorectal cancer through the miR-7-5p/Akt3/Wnt-β-catenin pathway.铜绿假单胞菌甘露糖敏感血凝菌毛(PA-MSHA)通过miR-7-5p/Akt3/ Wnt-β-连环蛋白信号通路对西妥昔单抗耐药的结直肠癌发挥强大的活性作用。
Transl Cancer Res. 2024 Aug 31;13(8):4441-4458. doi: 10.21037/tcr-23-2211. Epub 2024 Aug 23.
2
Circular RNA circ_0058123 Targets the miR-939-5p/RAC1 Pathway to Promote the Development of Colorectal Cancer.环状 RNA circ_0058123 通过靶向 miR-939-5p/RAC1 通路促进结直肠癌的发展。
Biochem Genet. 2024 Jun;62(3):1485-1501. doi: 10.1007/s10528-023-10485-8. Epub 2023 Aug 29.
3
The Impact of a Six-Year Existing Screening Programme Using the Faecal Immunochemical Test in Flanders (Belgium) on Colorectal Cancer Incidence, Mortality and Survival: A Population-Based Study.
《六年粪便免疫化学试验筛查计划对佛兰德(比利时)结直肠癌发病率、死亡率和生存率的影响:一项基于人群的研究》。
Int J Environ Res Public Health. 2023 Jan 16;20(2):1654. doi: 10.3390/ijerph20021654.
4
Overall and stage-specific survival of patients with screen-detected colorectal cancer in European countries: A population-based study in 9 countries.欧洲国家筛查发现的结直肠癌患者的总体生存率和特定分期生存率:一项基于9个国家人群的研究。
Lancet Reg Health Eur. 2022 Jul 6;21:100458. doi: 10.1016/j.lanepe.2022.100458. eCollection 2022 Oct.
5
Prediction of Tumor Mutation Load in Colorectal Cancer Histopathological Images Based on Deep Learning.基于深度学习的结直肠癌组织病理学图像中肿瘤突变负荷预测
Front Oncol. 2022 May 24;12:906888. doi: 10.3389/fonc.2022.906888. eCollection 2022.